Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BE Group publishes the Annual Report for 2023

BE Group’s Annual Report for 2023 has now been published and is available on the Group’s website, www.begroup.com. The Swedish version is also available in European Single Electronic Format (ESEF). For further information, please contact:Peter Andersson, President and CEOTel: +46 706 53 76 55, email: peter.andersson@begroup.com Christoffer Franzén, CFOTel: +46 705 46 90 05, email: christoffer.franzen@begroup.com This information is information that BE Group AB (publ) is obliged to make public pursuant to the Securities Market Act. The information was submitted for publication

TORM plc capital increase in connection with delivery of one 2012-built LR2 vessel and RSU exercise as part of TORM’s incentive program

TORM has increased its share capital by 744,668 shares (corresponding to USD 7,446.68) in connection with the delivery of one 2012-built LR2 vessel and exercise of Restricted Share Units as part of TORM’s incentive program.   With reference to Company Announcement no. 22 dated 09 November 2023 where TORM plc (“TORM") announced the acquisition of eight LR2 product tanker vessels, TORM plc has increased its share capital by 698,590 A-shares (corresponding to a nominal value of USD 6,985.90) as a result of the delivery of the sixth of the eight LR2 vessels. The new shares relate to the

United Bankers Plc’s directed share issue without consideration for the payment of rewards under the management share-based incentive plan

United Bankers Plc STOCK EXCHANGE RELEASE 19 March 2024 at 10:45 EET   United Bankers Plc’s directed share issue without consideration for the payment of rewards under the management share-based incentive plan   The Board of Directors of United Bankers Plc has today decided that a total of 20,878 shares shall be issued without consideration on 19 March 2024 for the payment of rewards under the Company’s management share-based incentive plan. 13,415 shares shall be issued to the key persons belonging to the share-based incentive plan for the earning periods 2021–2023. 5,289

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 67 – 19 MARTS 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 30/24 and 31/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Communications & Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Post Stabilisation Notice- Randstad N.V. EUR 500mil 3.61% due 12 March 2029

Post Stabilisation Notice- Randstad N.V. EUR 500mil 3.61% due 12 March 2029March 19, 2024   Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.   Randstad N.V. EUR 500,000,000 3.61% Notes due 12 March 2029 Launched pursuant to the Issuer’s EMTN Programme, dated 28 February 2024   Commerzbank (contact: Ian Turner; telephone: +44 207 475 1817) hereby gives notice that no stabilisation (within the meaning of Article 3.2 (d) of the Market Abuse Regulation (EU Regulation 596/

Clinical trials: What to know before you invest | Health & Wealth #9 (Episode in English)

When developing new therapies or medicines, there are many hurdles along the way to reaching the market. If you do, that is. Failure is lurking at every step. A drug candidate must be safe and show clinicial efficacy in patients without severe side effects. The risks are significant and so are the costs, but if a project is successful, the reward could be enormous. So, how can you assess the risks involved?In this episode of Health & Wealth Jesper Prior Larsen from Aixial Group – a leading experts at clinical trials – walk us through some of the things you need to be aware of before

Risk Intelligence A/S signs agreement with major Hamburg-based ship owner/manager for the new Risk Intelligence System.

Risk Intelligence A/S (“Risk Intelligence” or "the Company") signs agreement with major Hamburg-based ship owner/manager (“the Client”) for the new Risk Intelligence System.The new Risk Intelligence System has attracted the major ship owner/manager, which has signed up with a short lead time. The Client will besides the System have access to some of the monthly and weekly intelligence reports.     The Client manages several hundred vessels globally and its security team who has selected Risk Intelligence as their intelligence partner to support them with a portfolio of intelligence

Irisity AB (publ) Awarded Major US Transportation Project Expansion.

Gothenburg, Sweden – March 19, 2024 – Irisity AB (publ), a provider of AI-driven video data management software has today been awarded a major transportation project expansion for an existing customer located on the East Coast of the United States.Irisity AB (publ) Awarded Major US Transportation Project Expansion. Gothenburg, Sweden – March 19, 2024 – Irisity AB (publ), a provider of AI-driven video data management software has today been awarded a major transportation project expansion for an existing customer located on the East Coast of the United States. Valued at approximately

Kemppi Oy and Kemppi Group Oy completed change negotiations

KEMPPI        PRESS RELEASE        19 MARCH 2024       10.00 EET Kemppi Oy and Kemppi Group Oy completed change negotiations Kemppi Oy and Kemppi Group Oy have completed change negotiations, which the companies announced on 13 February 2024. The aim of the negotiations was to ensure maintaining group’s competitiveness and cost efficiency of the welding business in the long term and strengthening the conditions for implementing growth strategy. At the start of the negotiations, the estimated need for permanent personnel reductions was max 40 personnel. The negotiations resulted in

SmartCella AB appoints Oskar Steneryd as new CFO

SmartCella Holding AB today announces that Oskar Steneryd has been appointed new Chief Financial Officer (CFO). Oskar Steneryd assumes the role on April 1, 2024, and most recently was Investment Director at Impilo, a Nordic-based investment company focused on the healthcare sector. Oskar will be a member of SmartCella’s Executive Management Team, based in the Stockholm head office.SmartCella is an innovative biotechnology company developing stem cell and RNA-based therapies in combination with novel delivery devices such as the FDA-cleared Extroducer. Oskar Steneryd’s recruitment adds

Notice to the 2024 Annual General Meeting of AFRY

The shareholders of AFRY AB (publ) are hereby given notice to the Annual General Meeting (the "AGM") on Tuesday 23 April 2024 at 14:00 (CEST) at the company’s head office at Frösundaleden 2A, Solna, Sweden. Registration starts at 13:30 (CEST).  The shareholders may also exercise their voting rights at the AGM by postal voting in accordance with the provisions of AFRY’s Articles of Association. Materials from the AGM, such as the President and CEO’s presentation and presentation material available at the AGM, will be available at www.afry.com/en the day after the AGM.Right to

Fighting data noise in industrial production - Process Genius launches fully configurable digital twin

Process Genius’s new digital twin platform, Genius Core, provides industrial manufacturers and process-focused industries with a fully configurable digital twin of their facilities, giving complete, real-time visibility over maintenance needs, safety, and operational efficiency from anywhere in the world.Joensuu, Finland (March 19th, 2024) – Finnish producer of 3D digital twins for industrial manufacturing Process Genius  has just announced the launch of its new, fully configurable digital twin Genius Core for the European market. Genius Core tackles the critical

Genexis expands FiberTwist Series with next-gen ONT with two 10GE LAN ports: XGS2418

Genexis, a leading PON Optical Network Terminal (ONT) vendor in Europe, continues to expand its FiberTwist portfolio by introducing FiberTwist XGS2418. Known for its Do-It-Yourself (DIY) installation due to the mechanism of a single “twist,” FiberTwist XGS2418 is a new-generation premium XGS-PON ONT.In the growing trend of high-speed open access networks, customers have asked for a solution that enables seamless transitions between Internet Service Providers (ISPs) without any service downtime, supporting speeds of up to 10 Gbps.  Featuring two 10GE LAN ports and two 1GE LAN ports, this

ANNUAL GENERAL MEETING IN CONCENTRIC

The Concentric AB board of directors has resolved to convene an annual general meeting of shareholders to be held Thursday, April 18, 2024. Further details on the proposals can be found in the notice convening the meeting, below. The notice is expected to be published in the Swedish Official Gazette (Post- och Inrikes Tidningar) and on the company’s website within the next few days. Annual general meeting in concentric AB The annual general meeting of Concentric AB will be held at 13.00 CET on Thursday, April 18, 2024 at Klara Strand, S:ta Clara, Klarabergsviadukten 90, in

The nomination committee of SaltX Technology proposes new Chairman and Board members ahead of the 2024 Annual General Meeting

As a part of SaltX’s preparation for its next phase of industrialization and commercialization, the nomination committee of SaltX Technology Holding AB (publ) (“SaltX” or the “Company”) proposes the election of a new Chairman and three new Board members at the 2024 Annual General Meeting.The nomination committee of SaltX’s proposals for resolution at the Annual General Meeting on 25 April 2024 regarding the number of Board members as well as the election of Board members and Chairman of the Board has today been submitted to the Company. The nomination committee of SaltX proposes that the

Cereno Scientific announces new patent issued in Mexico for Phase II drug candidate CS1

Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that the Company’s leading drug candidate CS1’s first patent family has obtained an issued patent in Mexico. This further strengthens the intellectual property rights for CS1, that is in late Phase II development for pulmonary arterial hypertension (PAH).“I am pleased to report that our leading drug candidate CS1 has obtained a patent issued by the Mexican authorities. Mexico is a large global pharmaceutical market, and as such an important

Valmet to supply the second Advantage DCT 200 tissue production line to Crown Paper Mill in Saudi Arabia

Valmet Oyj’s press release on March 19, 2024 at 9:30 a.m. EETCrown Paper Mill has decided to invest in a second Valmet’s Advantage DCT tissue line including an extensive automation package, flow control valves and Industrial Internet solutions to its mill in Saudi Arabia. The target of the investment is to meet the consumers’ increasing demand of high-quality tissue products with low environmental impact. The start-up is scheduled for the second half of 2025.The order is included in Valmet’s orders received of the first quarter 2024. The value of the order will not be disclosed.Valmet

Eevia Health Plc receives multiple sales orders for c. KSEK 518 (KEUR 50)

Eevia Health ("Eevia" or "The Company") received several sales orders totaling c 518 kSEK (50 kEUR) from various European customers.The sales orders are for the products Feno-Chaga M (Chaga extract), Feno-Myrtillus 25 Organic, Feno-Myrtillus 36 Organic (both bilberry extracts) and Fenoprolic 70 Organic (Pine bark extract). The orders came from several Finnish and European customers in the whole foods and drinks as well as supplement segments. Eevia has the product in stock, so it can deliver fast. These are repeat orders. Eevia expects further repeat orders in the future from the same

Notice of the Annual General Meeting of Coor Service Management Holding AB

The shareholders of Coor Service Management Holding AB (Reg. No 556742-0806) are invited to participate in the annual general meeting to be held on Friday, April 26, 2024 at 1.00 p.m. at Kista Entré, Knarrarnäsgatan 7, Kista, Stockholm, Sweden. Registration commences at 12.15 p.m.THE ENGLISH TEXT IS A TRANSLATION OF THE SWEDISH ORIGINAL VERSION. IN THE EVENT OF A CONFLICT BETWEEN THE ENGLISH AND THE SWEDISH TEXTS THE SWEDISH TEXT SHALL PREVAIL. The board of directors has decided that shareholders may exercise their voting rights at the annual general meeting also by postal voting in

Brain+ starts UK Pilot Project on CST-Therapist Companion in partnership with Age UK

· An important step in the company’s UK focused strategy plan building towards commercial release of CST-Therapist Companion and first sales later in 2024 · Age UK is the largest UK charity organization for seniors and a significant provider of Cognitive Stimulation Therapy (CST) to people with dementia · Two Age UK sites will each run a full CST program using a near-final English v 2.0 of CST-Therapist Companion to provide UK user feedback and cost-effectiveness data · Project output will feed into Medical Device certification of CST-Therapist Companion v2.0 for the UK market

Changes in reporting Industrial Equipment’s order intake and net sales with an impact on Industrial Equipment’s reported profitability

KONECRANES PLC CORPORATE PRESS RELEASE MARCH 19, 2024 09:30 AM EET   Changes in reporting Industrial Equipment’s order intake and net sales with an impact on Industrial Equipment’s reported profitability   Konecranes has decided to make changes in reporting Industrial Equipment’s orders received and net sales, which will also impact Industrial Equipment’s profitability.    Some of Port Solutions’ key components are manufactured at Konecranes’ Industrial Equipment factory in Hyvinkää. As these internal orders from Port Solutions have increased in recent years, Konecranes

NPRO: Takeover of Martin Linges vei 33 at Fornebu

Norwegian Property’s (NPRO’s) subsidiary, NPRO Holding AS, has taken over all shares in ML 33 Holding II AS as of 18 March 2024, which indirectly owns the shares in the company that owns the property Martin Linges vei 33 at Fornebu (the "Property"). The shares have been taken over for NOK 1. NPRO Holding is 100% holder of junior bond loan extended to one of the Property's holding companies. Former shareholder has tried to raise new capital to repair covenant breaches in loan agreements to the Property’s holding companies. There have also been attempts to divest the Property’s holding

AstraZeneca to acquire Fusion

19 March 2024 AstraZeneca to acquire Fusion to accelerate the development of next-generation radioconjugates to treat cancer Includes actinium-based clinical-stage radioconjugate targeting PSMA for prostate cancer, pipeline of radioconjugates and state-of-the-art R&D and manufacturing facilities AstraZeneca has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs). The acquisition marks a major step forward in AstraZeneca delivering on its ambition to transform

There are no items matching the current filter
There are no more items matching the current filter
Back to top